REFERENCES

 1.	Allen, B.W. 1981. Survival of tubercle bacilli in heat-fixed sputum smears. J Clin Pathol 34:719-722.

 2.	American Society of Heating, Refrigerating, and Air-Conditioning Engineers, Inc. 1991.  "Laboratories". In: ASHRAE Handbook, Heating, Ventilation, and Air-Conditioning Applications. p. 14.1-14.17.

 3.	American Thoracic Society. 1983a. Levels of laboratory services for mycobacterial diseases. Am Rev Respir Dis 128:213.

 4.	American Thoracic Society. 1983b. The levels of service concept in mycobacteriology.  Am Thorac Soc News, Summer 1983. p. 19-25.

 5.	Anonymous. 1992. Drugs for Parasitic Infections.  The Medical Letter on Drugs and Therapeutics. 34:17-26.  

 6.	Anonymous. 1980. Tuberculosis infection associated with tissue processing. Cal Morbid 30.

 7.	Artenstein, A.W., Hicks, C.B., Goodwin, B.S., Hilliard, J.K. 1991. Human Infection with B Virus Following a Needlestick Injury.  Rev Infect Dis 13:288-91.

 8.	Bacteriologist dies of meningitis. 1936. JAMA 106:129.

 9.	Baum, G.L., Lerner, P.I. 1971.  Primary pulmonary blastomycosis: a laboratory acquired infection.  Ann Intern Med 73:263-265.

10.	Beeman, E.A. 1950. Q fever - An epidemiological note. Pub Hlth Rep 65(2):88-92.

11.	Bernard, K.W., Parham, G.L., Winkler, W.G., Helmick, C.G. 1982. Q fever control measures: Recommendations for research of facilities using sheep. Inf Control 3:461-465.

12.	Biosafety in the Laboratory: Prudent Practices for the Handling and Disposal of Infectious Materials. 1989.  National Research Council.  National Academy Press, Washington, D.C.

13.	Blaser, M.J., Hickman, F.W., Farmer, J.J., III, Brenner, D.J., Balows, A. and Feldman, R.A. 1980. Salmonella typhi: the laboratory as a reservoir of infection. J Infect Dis 142:934-938.

14.	Bowen, G.S., Calisher, C.H., Winkler, W.G., Kraus, A.L., Fowler, E.H., Garman, R.H., Fraser, D.W., Hinman, A.R. 1975. Laboratory studies of a lymphocytic choriomeningitis virus outbreak in man and laboratory animals. Am J Epidemiol 102:233-40.

15.	Brown, P., Wolff, A., Gadusek, D.C. 1990. A simple and effective method for inactivating virus infectivity in formalin-fixed tissue samples from patients  with Cruetzfeldt-Jakob disease.  Neurology 40:887-890.

16.	Burke, D.S. 1977. Immunization against tularemia:  analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia. J Infect Dis 135:55-60.

17.	Burmeister, R.W., Tigertt, W.D., Overholt, E.L. 1962. Laboratory-acquired pneumonic plague. Ann Intern Med 56:789-800.

18.	Bush, J.D. 1943. Coccidioidomycosis. J Med Assoc Alabama 13:159-166.

19.	Burstyn, D.G., Baraff, L.J., Peppler M.S., Leake, R.D., et al. 1983.  Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis.  Infection and Immunity 41(3):1150-6.

20.	Caplen, H., Peters, C.J., and Bishop, D.H.L. 1985. Mutagen-directed Attenuation of Rift Valley Fever Virus as a Method for Vaccine Development.  J Gen Virol 66:2271-2277.

21.	Carougeau, M. 1909. Premier cas Africain de sporotrichose de deBeurmann: Transmission de la sporotrichose du mulet a l'homme. Bull Mem Soc Med Hop (Paris) 28:507-510.

22.	Cavenaugh, D.C., Elisberg, B.L., Llewellyn, C.H., Marshall, J.D., Jr., Rust, J.H., Williams, J.E., and Meyer, K.F. 1974. Plague Immunization IV. Indirect evidence for the efficacy of plague vaccine. J Infect Dis 129: (Supplement) S37-S40.

23.	Center for Disease Control, Office of Biosafety. 1974. Classification of Etiologic Agents on the Basis of Hazard, 4th Edition. U.S. Department of Health, Education and Welfare, Public Health Service.

24.	Center for Disease Control. 1976. Unpublished Data. Center for Infectious Diseases. U.S. Department of Health, Education and Welfare, Public Health Service.

25.	Center for Disease Control. 1977. Rabies in a laboratory worker New York. MMWR 26(22):183-184.

26.	Center for Disease Control. 1978. Laboratory-acquired endemic typhus. MMWR 27(26):215-216.

27.	Center for Disease Control. 1978. Meningococcal Polysaccharide vaccines. Recommendations of the Immunization Practices Advisory Committee (ACIP) and Mortality Weekly Report 27(35):327-328.

28.	Centers for Disease Control. 1979. Q fever at a university research center - California. MMWR 28(28):333-334.

29.	Centers for Disease Control. 1980. Chagas' disease, Kalamazoo, Michigan. MMWR 20(13):147-8.

30.	Centers for Disease Control. 1980. Recommendations for initial management of suspected or confirmed cases of Lassa fever. MMWR 28(52): Suppl:3S-12S.

31.	Centers for Disease Control. 1980. Smallpox Vaccines. Recommendation of the Immunization Practices Advisory Committee (ACIP). MMWR 29:417-420.

32.	Centers for Disease Control. 1981.  Recommendations of the Immunization Practices Advisory Committee (ACIP) Diphtheria, Tetanus, and Pertussis. MMWR 30(32):392-396. 

33.	Centers for Disease Control. 1982. Recommendations of the Immunization Practices Advisory Committee (ACIP). Poliomyelitis prevention. MMWR 29(3):22-26 and 31-34.

34.	Centers for Disease Control. 1982.  Plague vaccine. Selected recommendations of the Public Health Service Advisory Committee on Immunization Practices (ACIP). MMWR 40 (RR-12): 41-42.

35.	Centers for Disease Control. 1985.  Pertussis - Washington, 1984. MMWR 34(26):90-400.  

36.	Centers for Disease Control. 1985. Revision of the case definition of acquired immunodeficiency syndrome for national reporting - United States.  MMWR 34:373-5.  

37.	Centers for Disease Control. 1986. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotrophic virus type III/lymphadenopathy-associated virus.  MMWR 35:152-5.        

38.	Centers for Disease Control. 1986. Diagnosis and management of mycobacterial infection and disease in persons with human T-lymphotrophic virus type III/lymphadenopathy-associated virus infection.  MMWR 35:448-52. 

39.	Centers for Disease Control. 1987.  Guidelines for prevention of Herpesvirus simiae (B virus) infection in monkey handlers.  MMWR, 36:680-2,687-9.

40.	Centers for Disease Control. 1987. Recommendations for prevention of HIV transmission in health-care settings.  MMWR 36(suppl 2):3S-18S.

41.	Centers for Disease Control. 1987. Public Health Service guidelines for counseling and antibody testing to prevent HIV infections and AIDS.  MMWR 36:509-15.  

42.	Centers for Disease Control. 1987. Revision of the Centers for Disease Control surveillance case definition for acquired immunodeficiency syndrome.  MMWR 36(suppl 1):1S-15S.

43.	Centers for Disease Control. 1988.  Update: Universal Precautions for Prevention of Transmission of Human Immunodeficiency Virus, Hepatitis B Virus and Other Bloodborne Pathogens in Healthcare Settings.  MMWR, 37:377-382, 387, 388. 

44.	Centers for Disease Control. 1988. Guidelines to prevent simian immunodeficiency virus infection in laboratory workers. MMWR 37:693-704.

45.	Centers for Disease Control. 1987. Recommendations for Prevention of HIV Transmission in Health-Care Settings.  MMWR, 36(25):1-7.

46.	Centers for Disease Control. 1990.  Recommendations of the Immunizations Practices Advisory Committee (ACIP) - Inactivated hepatitis B virus vaccine. MMWR 39, No. RR-2. 

47.	Centers for Disease Control. 1990. Guidelines for Preventing the Transmission of Tuberculosis in Health-Care Settings, with Special Focus on HIV-Related Issues.  MMWR 39, No. RR-17.

48.	Centers for Disease Control. 1990. Public Health Service statement on management of occupational exposure to human immunodeficiency virus, including considerations regarding Zidovudine postexposure use. 1990.  MMWR 39, No. RR-1.

49.	Centers for Disease Control. 1991. Laboratory-acquired meningococcemia - California and Massachusetts. MMWR 40(3):46-47,55.

50.	Centers for Disease Control. 1991. Recommendations of the Immunization Practices Advisory Committee (ACIP) -Diphtheria, Tetanus and Pertussis: Recommendations for Vaccine Use and Other Preventive Measures.  MMWR 40, No. RR-10.

51.	Centers for Disease Control. 1991. Recommendations of the  Immunization Practices Advisory Committee (ACIP) -MMWR 40, No. RR-12.

52.	Centers for Disease Control. 1991. Vaccinia (Smallpox) Vaccine, Recommendations of the  Immunization Practices Advisory Committee (ACIP) - MMWR 40, No. RR-14.

53.	Centers for Disease Control. 1992. Seroconversion to simian immunodeficiency virus in two laboratory workers. MMWR 41:678-681.

54.	Centers for Disease Control. 1992. National Action Plan to Combat Multi-drug-Resistant Tuberculosis.  Meeting the Challenge of Multi-drug-Resistant Tuberculosis: Summary of a Conference.  Management of Persons Exposed to Multi-drug-Resistant Tuberculosis - MMWR 41, No. RR-11.

55.	Centers for Disease Control. HIV/AIDS Surveillance Report, October 1992:14.

56.	Conant, N.F. 1955. Development of a method for immunizing man against coccidioidomycosis, Third Quarterly Progress Report. Contract DA-18-064-CML-2563, Duke University, Durham, NC. Available from Defense Documents Center, AD 121-600.

57.	Cooper, C.R., Dixon, D.M., Salkin, I.F.: Laboratory acquired sporotrichosis. 1992. J Med Vet Mycol  30:169-171.

58.	Denton, J.F., DiSalvo, A.F., Hirsch, M.L. 1967. Laboratory-acquired North American blastomycosis. JAMA 199:935-936.

59.	Dickson, E.C. 1937. Coccidioides infection: Part I. Arch Intern Med 59: 1029-1044.

60.	Dickson, E.C. 1937. "Valley fever" of the San Joaquin Valley and fungus coccidioides. Calif Western Med 47:151-155.

61.	Dickson, E.C., Gifford, M.A. 1938. Coccidioides infection (coccidioidomycosis): II. The primary type of infection. Arch Intern Med 62:853-871.

62.	Diena, B.B., Wallace, R., Ashton, F.E., Johnson, W. and Patenaude, B. 1976. Gonococcal conjunctivitis: accidental infection. Can Med Assoc J 115:609,612.

63.	Donham, K.J. and Leininger, J.R. 1977.  Spontaneous leprosy-like disease in a chimpanzee. J Infect Dis 136:132-136.

64.	Dowdle, W.R. and Hattwick, M.A.W. 1977. Swine influenza virus infections in humans. J Infect Dis 136: Suppl: S386-389.

65.	Edmond, R.T.D., Evans, B., Bowen, E.T.W. and Lloyd, G. 1977. A Case of Ebola virus infection.  Br Med J 2:541-544.

66.	Ellingson, H.V., Kadull, P.J., Bookwalter, H.L., Howe, C. 1946. Cutaneous anthrax: report of twenty-five cases. JAMA 131:1105-8.

67.	Evans, N. 1903 . A clinical report of a case of blastomycosis of the skin from accidental inoculation. JAMA 40:1172-1175.

68.	Eyles, D.E., Coatney, G.R., and Getz, M.E. 1960. Vivax-type malaria parasite of macaques transmissible to man. Science 131:1812-1813.

69.	Fava, A. 1909. Un cas de sporotrichose conjonctivale et palpebrale primitives. Ann Ocul (Paris) 141:338-343.

70.	Favero MS, Bond, WW. 1991. Sterilization, Disinfection and Antisepsis in the Hospital. In: Lennette EH, Balows A, Hausler WJ, Shadomy HJ, eds. Manual of Clinical Microbiology, 4th ed. Washington, DC: American Society for Microbiology: 183-200. 

71.	Federal Register. 1976. Recombinant DNA Research Guidelines. 41: 27902-27943

72.	Federal Register. 1986. Guidelines for Research Involving Recombinant DNA Molecules. 51:16958-16968.

73.	Fielitz, H. 1910. Ueber eine Laboratoriumsinfektion mit dem Sporotrichum de Beurmanni. Centralbl Bakteriol Parasitenk Abt I Orig 55:361-370.

74.	Fitzgerald, J.J., Johnson, R.C., Smith, M. 1976. Accidental laboratory infection with Treponema pallidum. Nichols strain. J Am Vener Dis Assoc 3:76-78.

75.	Furcolow, M.L. 1961. Airborne Histoplasmosis. Bact Rev 25:301-309.

76.	Gajdusek, D.C., Gibbs, C.J., Asher, D.M., Brown, P., Diwan, A., Hoffman, P., Nemo, G., Rohwer, R. and White, L. 1977. Precautions in the medical care and in handling materials from patients with transmissible virus dementia (Creutzfeldt-Jakob Disease). N Engl J Med 297:1253-1258.

77.	Good, R.C., Snider, D.E., Jr. 1982. Isolation of nontuberculosis mycobacteria in the U.S., 1980. J Infect Dis 146:829-833.

78.	Green, R.N., Tuffnell, P.G. 1968. Laboratory acquired melioidosis. Am J Med 44: 599-605.

79.	Grist, N.R., Emslie, J.A.N. 1985. Infections in British clinical laboratories, 1982-3. J Clin Pathol 38:721-725.

80.	Grist, N.R., Emslie, J.A.N. 1987. Infections in British clinical laboratories, 1984-5. J Clin Pathol 40:826-829.

81.	Gutteridge, W.E., Cover, B., Cooke, A.J.D. 1974. Safety precautions for working with Trypanosoma cruzi. Trans R Soc Trop Med Hyg 68:161.

82.	Hackstadt, T. 1986. Antigenic variation in the phase I lipopolysaccharide of Coxiella burnetii isolates.  Infect Immun 52:377-340.

83.	Halde, C. 1964. Percutaneous Cryptococcus neoformans inoculation without infection. Arch Dermatol. 89:545.

84.	Hanel, E., Jr. and Kruse, R.H. 1967. Laboratory-acquired mycoses. Department of the Army, Miscellaneous Publication 28.

85.	Hanson, R.P., et al. 1950. Human infections with the virus of vesicular stomatitis. J Lab Clin Med 36:754-758.

86.	Hanson, R.P., Sulkin, S.E., Buescher, E.L., Hammond, W.McD., McKinney, R.W., and Work, T.E. 1967. Arbovirus infections of laboratory workers. Science 158:1283-1286.

87.	Harrell, E.R. 1964. The known and the unknown of the occupational mycoses, p. 176-178. In: Occupational Diseases Acquired From Animals. Continued Education Series No. 124, Univ Mich Sch Pub Hlth, Ann Arbor, MI.

88.	Harrington, J.M., and Shannon, H.S. 1976. Incidence of tuberculosis, hepatitis, brucellosis and shigellosis in British medical laboratory workers. Br Med J 1:759-762.

89.	Hattwick, M.A.W., O'Brien, R.J., Hanson, B.F. 1976. Rocky Mountain Spotted Fever: epidemiology of an increasing problem. Ann Intern Med 84: 732-739.

90.	Hennessen, W. 1971. Epidemiology of "Marburg Virus" disease. In: Martini, G.A., Siegert, R. eds., Marburg Virus Disease. New York: Springer-Verlag 161-165.

91.	Herwaldt, B.L., Juranek, D.D. 1993. Laboratory-acquired malaria, leishmaniasis, trypanosomiasis, and toxoplasmosis. Am J Trop Med Hyg 48:313-323.

92.	Holmes, G.P., Hilliard, J.K., Klontz, K.C., Rupert, A.H., Schindler, C.M., Parrish, E., Griffin, D.G., Ward, G.S.,Bernstein, N.D., Bean, T.W., Ball, M.R., Brady, J.A., Wilder, M.H., Kaplan, J.E. 1990. B Virus (Herpesvirus simiae) Infection in Humans: Epidemiologic Investigation of a Cluster.  Ann of Int Med 112:833-839.

93.	Holzer, E. 1962. Botulism caused by inhalation. Med Klin 41:1735-1740.

94.	Houghton, M., Weiner, A., Han, J., Kuo, G., Choo, Q-L. 1991. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral disease.  Hepatology 14:381-388.

95.	Huddleson, I.F. and Munger, M. 1940. A study of an epidemic of brucellosis due to Brucella melitensis. Am J Public Health 30:944-954.

96.	International Catalog of Arboviruses Including Certain Other Viruses of Vertebrates. 1985. The Subcommittee on Information Exchange of the American Committee on Arthropod-borne Viruses.  Third edition.  N. Karabatsos, Editor.  American Society for Tropical Medicine and Hygiene.  San Antonio, TX.

97.	Jacobson, J.T., Orlob, R.B., Clayton, J.L. 1985. Infections acquired in clinical laboratories in Utah. J Clin Microbiol 21:486-489.

98.	Jahrling, P.B., Peters, C.J. 1992. Lymphocytic choriomeningitis virus, a neglected pathogen of man.  Arch Pathol Lab Med 116:486-8.

99.	Jarvis, W.R. 1982. Precautions for Creutzfeldt-Jakob Disease. Infect Control 3:238-239.

100.	Jeanselme, E., Chevallier, P. 1910. Chancres sporotrichosiques des doigts produits par la morsure d'un rat inocule de sporotrichose. Bull Mem Soc Med Hop (Paris) 30:176-178.

101.	Jeanselme, E., Chevallier, P. 1911. Transmission de la sporotrichose a l'homme par les morsures d'un rat blanc inocule avec une nouvelle variete de Sporotrichum: Lymphangite gommeuse ascendante. Bull Mem Soc Med Hop (Paris) 31:287-301.

102.	Kaufmann, A.F., Anderson, D.C. 1978. Tuberculosis control in nonhuman primates. In: Montali, R.J. (ed.). Mycobacterial Infections of Zoo Animals. Washington, D.C.: Smithsonian Institution Press, 227-234.
103.	Khabbaz, R.F, Rowe, T., Murphey-Corb, M., et al. 1992. Simian immunodeficiency virus needlestick accident in a laboratory worker. Lancet 340:271-273.

104.	Kiley, M.P., Bowel, E.T.W., Eddy, G.A., Isaacson, M., Johnson, K.M., McCormick, J.B., Murphy, F.A., Pattyn, S.R., Peters, D., Prozesky, W., Regnery, R., Simpson, D.I.H., Slenczka, W., Sureau, P., van der Groen, G., Webb, P.A., and Sulff, H. 1982. Filoviridae: a taxonomic home for Marburg and Ebola viruses? Intervirology 18:24-32.

105.	Klutsch, K., Hummer, N., Braun, H., Heidland, A. 1965. Zur Klinik der Coccidioidomykose. Deut Med Wochensch 90:1498-1501.

106.	Kurt, T.L.,  Yeager, A.S., Guenette S., et al. 1972.  Spread of pertussis by hospital staff.  JAMA 221:264.

107.	Larsh, H.W., Schwartz, J. 1977. Accidental inoculation-blastomycosis. Cutis 19:334-336.

108.	Larson, D.M., Eckman, M.R., Alber, C,L., Goldschmidt, V.G. 1983. Primary cutaneous (inoculation) blastomycosis: an occupational hazard to pathologists.  Amer J Clin Pathol 79:253-25.

109.	Leifer, E., Gocke, D.J., Bourne, H. 1970. Lassa fever, a new virus disease of man from West Africa. II. Report of a laboratory-acquired infection treated with plasma from a person recently recovered from the disease. Am J Trop Med Hyg 19:677-9.

110.	Lettau, L.A. 1991. Nosocomial transmission and infection control aspects of parasites and ectoparasitic diseases: Part I. Introduction/enteric parasites.  Part II. Blood and tissue parasites. Infect Control Hosp Epidemiol 12:59-65;111-121.

111.	Levine, M.M., Kaper, J.B., Black, R.E., Clements, M.C. 1983.  New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.  Microbiol Reviews 47:510-550.

112.	Linneman, C.C., Ramundo, N., Perlstein, P.H., et al. 1975.  Use of pertussis vaccine in an epidemic involving hospital staff.  Lancet 2:540.

113.	Looney, J.M., Stein, T. 1950. Coccidioidomycosis. N Engl J Med 242:77-82.

114.	Magneson, H.J., Thomas, E.W., Olansky, S., Kaplan, B.L., De Mello, L., Cutler, J.C. 1956. Inoculation syphilis in human volunteers.  Medicine 35:33-82.

115.	Marchoux, P.E. 1934. Un cas d'inoculation accidentelle du bacille de Hanson en pays non lepreux. Int J Lepr 2:1-7.

116. 	Martin L.S., McDougal, J.S., Loskoski, S.L. 1985. Disinfection and inactivation of the human T lymphotrophic virus type III/lymphadenopathy-associated virus. J Infect Dis 152:400-3. 
 
117.	Martini, G.A., Schmidt, H.A. 1968. Spermatogenic transmission of Marburg virus. Klin Wschr 46:398-400.

118.	Mathiot. C.C., Grimaud,G., Garrey, P., Bouguety, J.C., Mada, A., Daguisy, A.M., Georges, A.J. 1990. An Outbreak of Human Semliki Forest Virus Infections in Central African Republic. Am J Trop Med Hyg 42:386-393.

119.	McAleer, R. 1980. An epizootic in laboratory guinea pigs due to Trichophyton mentagrophytes. Aust Vet J 56:234-236.

120.	McCray, E., Cooperative Needlestick Study Group. 1986.  Occupational risk of the acquired immunodeficiency syndrome among health-care workers.  N Engl J Med 314:1127-32. 

121.	McDade, J.E., Shepard, C.C. 1979. Virulent to avirulent conversion of Legionnaire's disease bacterium (Legionella pneumophila) - its effect on isolation techniques. J Infect Dis 139:707-711.

122.	McKinney, R.W., Wasserman, B., Carpenter, M., Kent, M.D., Manning, C., Spillane, M., Richmond, J.Y. 1985. XXVII Biological Safety Conference, Salk Institute for Biological Studies, La Jolla, CA.  

123.	Melnick, J.L., Wenner, H.A., Phillips, C.A. 1979. Enteroviruses. In: Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections, 5th edition. Lennette, E.H. and Schmidt, N.J., Eds., Washington, D.C., American Public Health Association, pp. 471-534.

124.	Meyer, K.F. 1915. The relationship of animal to human sporotrichosis: Studies on American sporotrichosis III. JAMA 65:579-585.

125.	Meyer, K.F., Eddie, B.: 1941. Laboratory infections due to Brucella. J Infect Dis 68:24-32.

126.	Meyers, W.M., Walsh, G.P., Brown, H.L., Fukunishi, Y., Binford, C.H., Gerone, P.J.,  Wolf, R.H. 1980. Naturally acquired leprosy in a mangabey monkey (Cercocebus sp.) Int J Lepr 48:495-496.

127.	Miller, C.D., Songer, J.R., Sullivan, J.F. 1987. A twenty-five year review of laboratory acquired human infections at the National Animal Disease Center. Am Ind Hyg Assoc J 48:271-275.

128.	Miyamura, T., Saito, I., Katayama, T., Kikuchi, S., Tateda, A., Houghton, M., Choo, Q-L., Kuo, G. 1990. Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: application to diagnosis and blood screening for post-transfusion hepatitis.  Proc Natl Acad Sci USA 87:983-987.

129.	Morisset, R., Spink, W.W. 1969. Epidemic canine brucellosis due to a new species, Brucella canis. Lancet 2:1000-2.

130.	Morse, S.I. 1968. Pertussis in Adults (editorial). Ann Intern Med. 68:953.

131.	Müller, H.E. 1988. Laboratory-acquired mycobacterial infection. Lancet 2:331.

132.	Murray, J.F., Howard, D.H. 1964.  Laboratory-acquired histoplasmosis. Am Rev Respir Dis 89:631-640.

133.	Nabarro, J.D.N. 1948. Primary pulmonary coccidioidomycosis: Case of laboratory infection in England. Lancet 1:982-984.

134.	National Committee for Clinical Laboratory Standards (NCCLS). 1991.  Protection of laboratory workers from infectious disease transmitted by blood, body fluids, and tissue.  Tentative Guideline.  M29-T2, Vol. 11, No. 14.  

135.	Nelson, J.D. 1978.  The changing epidemiology of pertussis in young infants.  The role of adults as reservoirs of infection.  Am J Dis Child 132:371.

136.	National Sanitation Foundation Standard 49. 1983. Class II (Laminar Flow) Biohazard Cabinetry. Ann Arbor, Michigan.

137.	Norden, A. 1951. Sporotrichosis: Clinical and laboratory features and a serologic study in experimental animals and humans. Acta Pathol Microbiol Scand. Suppl. 89:3-119.

138.	Oates, J.D., Hodgin, U.G., Jr. 1981.  Laboratory-acquired Campylobacter enteritis.  South Med J 74:83.

139.	Office of Research Safety, National Cancer Institute, and the Special Committee of Safety and Health Experts. 1978. Laboratory Safety Monograph: A Supplement to the NIH Guidelines for Recombinant DNA Research. Bethesda, MD, National Institutes of Health.

140.	Oliphant, J.W., Parker, R.R. 1948. Q fever: Three cases of laboratory infection. Public Health Rep 63(42):1364-1370.

141.	Oliphant, J.W., Gordon, D.A., Meis, A., Parker, R.R. 1949. Q fever in laundry workers, presumably transmitted from contaminated clothing. Am J Hyg 49(1):76-82.

142.	Oliver, J., Reusser, T.R. 1942. Rapid method for the concentration of tubercle bacilli. Am Rev Tuberc 45:450-452.

143.	Olle-Goig, J. and Canela-Soler, J.C. 1987. An outbreak of Brucella melitensis infection by airborne transmission among laboratory workers. Am J Publ Hlth 77:335-338.

144.	Oster, C.N., et al. 1977. Laboratory-acquired Rocky Mountain spotted fever. The hazard of aerosol transmission. N Engl J Med 297:859-862.

145.	Palmer, A.E. 1987. B Virus, Herpesvirus simiae: historical perspective.  J. Med. Primatol 16:99-130.

146.	Parker, C. 1992. Dept. of Microbiology, University of Missouri, Columbia, Missouri (personal communication). 

147.	Parritt, R.J., Olsen, R.E. 1947. Two simultaneous cases of leprosy developing in tattoos. Am J Pathol 23:805-817.

148.	Patterson, W.C., Mott, L.O., Jenney, E.W. 1958. A study of vesicular stomatitis in man. J Am Vet Med Assoc 133(1):57-62.

149.	Penner, J.L., Hennessy, J.N., Mills, S.D., Bradbury, W.C. 1983.  Application of serotyping and chromosomal restriction endonuclease digest analysis in investigating a laboratory-acquired case of Campylobacter jejuni enteritis. J Clin Microbiol 18:1427-1428.

150.	Perkins, F.T., Hartley, E.G. 1966. Precautions against B virus infection. Brit Med J 1:899-901.

151.	Pike, R.M. 1976. Laboratory-associated infections: Summary and analysis of 3,921 cases. Hlth Lab Sci 13:105-114.

152.	Pike, R.M. 1978. Past and present hazards of working with infectious agents. Arch Path Lab Med 102:333-336.

153.	Pike, R.M. 1979. Laboratory-associated infections: incidence, fatalities, causes and prevention. Ann Rev Microbiol 33:41-66.

154.	Pike, R.M., Sulkin, S.E., Schulze, M.L. 1965. Continuing importance of laboratory-acquired infections. Am J Public Health 55:190-199.

155.	Prescott, J.F., Karmali, M.A. 1978. Attempts to transmit Campylobacter enteritis to dogs and cats (letter). Can Med Assoc J 119:1001-1002.

156.	Reid, D.D. 1957. Incidence of tuberculosis among workers in medical laboratories. Brit Med J 2:10-14.

157.	Report of the Committee of Inquiry into the Smallpox Outbreak in London in March and April 1973. 1974. Her Majesty's Stationery Office, London.

158.	Resnick L, Veren K, Salahuddin, SZ, Tondreau S, Markham PD. 1986. Stability and inactivation of HTLV-III/LAV under clinical and laboratory environments. JAMA 255:1887-91.  

159.	Richardson, J.H. 1973. Provisional summary of 109 laboratory-associated infections at the Center for Disease Control, 1947-1973. Presented at the 16th Annual Biosafety Conference, Ames, Iowa.

160.	Riley, R.L. 1957. Aerial dissemination of pulmonary tuberculosis. Am. Rev Tuberc 76:931-941.

161.	Riley, R.L. 1961. Airborne pulmonary tuberculosis. Bacteriol Rev 25:243-248.
162.	Robertson, D.H.H., Pickens, S., Lawson, J.H., Lennex, B. 1980. An accidental laboratory infection with African trypanosomes of a defined stock. I and II. J Inf 2:105-112, 113-124.

163.	Robinson, D.A. 1981. Infective dose of Campylobacter jejuni in milk. Brit Med J 282:1584.

164.	Rutala, WA. 1990. APIC guideline for selection and use of disinfectants.  Am. J. Infection Control. 18:99-117.

165.	Samuel, J.E., Frazier, M.E., Mallavia, L.P. 1985.  Correlation of plasmid type and disease caused by Coxiella burnetii.  Infect Immun 49:775-779.  

166.	Sastaw, S., Carlisle, H.N. 1966. Aerosol infection of monkeys with Rickettsia rickettsii. Bact Rev 30:636-645.

166a.	Schlech, W.F., Turchik, J.B., Westlake, R.E.Jr., Klein, G.C., Band, J.D., Weaver, R.E. 1981. Laboratory-acquired infection with Pseudomona pseudomallie (meliodosis). N Eng J Med 305:1133-1135

167.	Schochetman, G., George, J.R. 1991.  AIDS Testing: Methodology and Management Issues.  Springer-Verlag, New York.

168.	Schwarz, J., Baum, G.L. 1951. Blastomycosis. Amer J Clin Pathol 21:999-1029.

169.	Segretain, G. 1959. Penicillium marnefii, n. sp., agent d'une mycose du systeme reticulo-endothelial.  Mycopathol Mycol Appl 11:327-353.

170.	Skinholj, P. 1974. Occupational risks in Danish clinical chemical laboratories. II Infections. Scand J Clin Lab Invest 33:27-29.

171.	Smith, C.E. 1950. The hazard of acquiring mycotic infections in the laboratory. Presented at 78th Ann. Meeting Am Pub Hlth Assoc, St. Louis, MO.

172.	Smith, C.E., Pappagianis, D., Levine, H.B., Saito, 1961. Human coccidioidomycosis. Bacteriol Rev 25:310-320.

172a.	Smith, D.K., Neal, J.J., Holmberg, S.D., Centers for Disease Control Idiopathic CD4-T-lymphocytopenia Task Force. 1992. Unexplained opportunistic infections in CD4-T-lymphocytopenia in persons without HIV infection, U.S. New England Journal of Medicine (submitted by Journal request).

173.	Smith, D.T., Harrell, E.R., Jr. 1948. Fatal Coccidioidomycosis: A case of laboratory infection. Am Rev Tuberc 57:368-374.

174.	Smithwick, R.W., Stratigos, C.B. 1978. Preparation of acid-fast microscopy smears for proficiency testing and quality control. J Clin Microbiol 8:110-111.

175.	Spinelli, J.S., et al. 1981. Q fever crisis in San Francisco: Controlling a sheep zoonosis in a lab animal facility. Lab Anim 10(3):24-27.

176.	Spink, W.W. 1956. The Nature of Brucellosis.  Minneapolis, The University of Minnesota Press, pp. 106-108.

177.	Sterne, M., Wertzel, L.M. 1950. A new method of large-scale production of high-titer botulinum formol-toxoid types C and D. J Immunol 65:175-183.

178.	Subcommittee on Arbovirus Laboratory Safety for Arboviruses and Certain Other Viruses of Vertebrates. 1980. Am J Trop Med Hyg 29(6):1359-1381.

179.	Sulkin, S.E., Pike, R.M. 1949. Viral Infections  Contracted in the Laboratory. New Engl J Med 241(5):205-213.

180.	Sulkin, S.E., Pike, R.M. 1951. Survey of laboratory-acquired infections. Am J Public Health 41(7):769-781.

181.	Sullivan, J.F., Songer, J.R., Estrem, I.E. 1978. Laboratory-acquired infections at the National Animal Disease Center, 1960-1976. Health Lab Sci 15(1):58-64.

182.	Tesh, R.B. and Schneidau, J.D. Jr. 1966. Primary cutaneous histoplasmosis. New Engl J Med 275:597-599.

183.	Thompson, D.W., Kaplan, W. 1977. Laboratory-acquired sporotrichosis. Sabouraudia 15:167-170.

184.	Tomlinson, C.C., Bancroft, P. 1928. Granuloma coccidioides: Report of a case responding favorably to antimony and potassium tartrate. JAMA 91:947-951.

185.	Tosh, F.E., Balhuizen, J., Yates, J.L., Brasher, C.A. 1964. Primary cutaneous histoplasmosis: Report of a case. Arch Intern Med 114:118-119.

186.	U.S. Congress, 1988.  Medical Waste Tracking Act of 1988.  H.R. 3515, 42 U.S.C. 6992-6992k.

187.	U.S. Department of Labor, Occupational Safety and Health Administration.  1991.  Occupational Exposure to Bloodborne Pathogens, Final Rule.  Fed. Register 56:64175-64182.  

188.	U.S. Environmental Protection Agency. 1986. EPA guide for infectious waste management. Washington DC:  U.S. Environmental Protection Agency; Publication no. EPA/530-5W-86-014.  

189.	Walsh, G.P., Storrs, E.E., Burchfield, H.P. Cottrel, E.H., Vidrine, M.F., Binford, C.H. 1975. Leprosy-like disease occurring naturally in armadillos. J Reticuloendothel Soc 18:347-351.

190.	Wedum, A.G., Kruse, R.H. 1969.  Assessment of risk of human infection in the microbiology laboratory. Misc Pub 30, Industrial Health and Safety Directorate, Fort Detrick, Frederick, Md.

191.	Wedum, A.G., Barkley, W.E., Hellman, A. 1972. Handling of infectious agents. J Am Vet Med Assoc 161:1557-1567.

192.	Wedum, A.G. History of Microbiological Safety. 1975. 18th Biological Safety Conference. Lexington, Kentucky.

193.	Weigler, B.J. 1992. Biology of B Virus in Macaque and Human Hosts: A Review.  Clin Infect Dis 14:555-67.

194.	Weissenbacher, M.C., Grela, M.E., Sabattini, M.S., Maiztegui, J.I., Coto, C.E., Frigerio, M.J., Cossio, P.M., Rabinovich, A.S., Oro, J.G.B. 1978. Inapparent infections with Junin virus among laboratory workers. J Infect Dis 137:309-313.

195.	Welsh, H.H., Lennette, E.H., Abinanti, F.R., Winn, J.F. 1951.  Q fever in California IV.  Occurrence of Coxiella burnetii in the placenta of naturally infected sheep.  Public Health Rep.  66:1473-1477.  

196.	Wells, D.L., Lipper, S.L., Hilliard, J.K., Stewart, J.A., Holmes, G.P., Herrmann, K.L., Kiley, M.P., Schonberger, L.B. 1989. Herpesvirus simiae Contamination of Primary Rhesus Monkey Kidney Cell Cultures.  Centers for Disease Control Recommendations to Minimize Risks to Laboratory Personnel.  Diagn Microbiol Infect Dis 12:333-336.

197.	Wilder, W. H., McCullough, C.P. 1914. Sporotrichosis of the eye. JAMA 62:1156-1160.

198.	Willems, W.R., Kaluza, G., Boschek, C.B., Bauer, H. 1979. Semliki Forest Virus: Cause of a Fatal Case of Human Encephalitis. Science 203:1127-1129.

199.	Wilson, J.W., Cawley, E.P., Weidman, F.D., Gilmer, W.S. 1955. Primary cutaneous North American blastomycosis. Arch Dermatol 71:39-45.

200.	Wilson, J.W., Smith, C.E., Plunkett, O.A. 1953. Primary cutaneous coccidioidomycosis; the criteria for diagnosis and a report of a case. Calif Med 79:233-239.

201.	Winkler, W.G. 1973. Airborne rabies transmission in a laboratory worker. JAMA 226(10):1219-1221.

202.	World Health Organization. 1978. Smallpox surveillance. Weekly Epidemiological Record 53(35):265-266.